Natural history of postoperative nonfunctioning pituitary adenomas: A systematic review and meta-analysis

Neuroendocrinology

Volumn 96, Issue 4, 2012, Pages 333-342

  Chen, Yong ^a,b   Wang, Cheng De ^a   Su, Zhi Peng ^a   Chen, Yun Xiang ^a   Cai, Lin ^a   Zhuge, Qi Chuan ^a   Wu, Zhe Bao ^a,c  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b Yueyang Second People's Hospital   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Meta analysis; Natural history; Nonfunctioning pituitary adenomas; Pituitary adenomas; Tumor growth free survival rate; Tumor volume doubling time

Indexed keywords

CANCER RADIOTHERAPY; DATA BASE; HISTORY; HUMAN; NONFUNCTIONING PITUITARY ADENOMA; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

ADENOMA; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; POSTOPERATIVE CARE; TREATMENT OUTCOME;

EID: 84871606746     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000339823     Document Type: Review

References (70)

1. Laws ER Jr, Vance ML: Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 1999; 10:327-336.
2. Mortini P, Barzaghi R, Losa M, Boari N, Giovanelli M: Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosur-ger y 2007; 60: 993-1002.
3. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J: The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 1991; 68:860-866.
4. Ebersold MJ QL, Laws ER Jr, Scheithauer B, Randall RV: Long-term results in transsphe-noidal removal of nonfunctioning pituitary adenomas. J Neurosurg 1986; 64:713-719.
5. Park P, Chandler WF, Barkan AL, Orrego JJ, Cowan JA, Griffith KA, Tsien C: The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 2004; 55:100-106.
6. Woollons AC, Hunn MK, Rajapakse YR, Toomath R, Hamilton DA, Conaglen JV, Ba-lakrishnan V: Non-functioning pituitary adenomas: Indications for postoperative radiotherapy. Clin Endocrinol (Oxf) 2000; 53: 713-717.
7. Colao A, Di Somma C, Pivonello R, Faggiano A, Lombardi G, Savastano S: Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer 2008; 15: 905-915.
8. Greenman Y, Tordjman K, Osher E, Veshchev I, Shenkerman G, Reider G II, Segev Y, Oua-knine G, Stern N: Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin Endocrinol (Ox f) 2005; 63: 39-44.
9. Gittoes NJ, Bates AS, Tse W, Bullivant B, Sheppard MC, Clayton RN, Stewart PM: Radiotherapy for non-function pituitary tumours. Clin Endocrinol (Oxf) 1998; 48:331-337.
10. Alameda C, Lucas T, Pineda E, Brito M, Uria JG, Magallon R, Estrada J, Barcelo B: Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy. J Endocrinol Invest 2005; 28:18-22.
11. Greenman Y, Ouaknine G, Veshchev I, Reider G II, Segev Y, Stern N: Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: Markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf) 2003; 58: 763-769.
12. Grigsby PW, Simpson JR, Fineberg B: Late regrowth of pituitary adenomas after irradiation and/or surgery. Hazard function a nalysis. Cancer 1989; 63: 1308-1312.
13. Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, Uttley D: The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 1993; 38: 571-578.
14. Tsang RW, Brierley JD, Panzarella T, Gospo-darowicz MK, Sutcliffe SB, Simpson WJ: Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 1994; 30:557-565.
15. Zierhut D FM, Adolph J, Erdmann J, Raue F, Wannenmacher M: External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 1995; 33: 307-314.
16. Flickinger JC, Nelson PB, Martinez AJ, Deutsch M, Taylor F: Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 1989; 63:2409-2414.
17. Breen P, Flickinger JC, Kondziolka D, Martinez AJ: Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 1998; 89: 933-938.
18. Fernandez A, Brada M, Zabuliene L, Karavi-taki N, Wass JA: Radiation-induced hypopi-tuitarism. Endocr Relat Cancer 2009; 16: 733-772.
19. McCord MW, Buatti JM, Fennell EM, Mendenhall WM, Marcus RB Jr, Rhoton AL, Grant MB, Friedman WA: Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997; 39: 437-444.
20. Rush S, Cooper PR: Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary mac-roadenomas. Int J Radiat Oncol Biol Phys 1997; 37: 1031-1034.
21. al-Mefty O, Kersh JE, Routh A, Smith RR: The long-term side effects of radiation therapy for benign brain tumors in adults. J Neu-rosurg 1990; 73: 502-512.
22. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, Rajan B, Traish D: Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 1992; 304: 1343-1346.
23. Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B: Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocri-nol (Oxf) 2002; 57: 713-717.
24. Erfurth EM, Bulow B, Svahn-Tapper G, Norrving B, Odh K, Mikoczy Z, Bjork J, Hagmar L: Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. J Clin Endocrinol Metab 2002; 87:4892-4899.
25. Hahn CA, Zhou SM, Raynor R, Tisch A, Light K, Shafman T, Wong T, Kirkpatrick J, Turkington T, Hollis D, Marks LB: Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocog-nitive dysfunction. Int J Radiat Oncol Biol Phys 2009; 73: 1082-1087.
26. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS: Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 1993; 72:2227-2233.
27. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M: Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 2005; 90: 800-804.
28. Muacevic A, Uhl E, Wowra B: Gamma knife radiosurgery for nonfunctioning pituitary adenomas. Acta Neurochir Suppl 2004; 91: 51-54.
29. Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD: Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 2002; 97:408-414.
30. Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD: Radiosurgery for nonfunc-tioning pituitary adenoma. Neurosurg Focus 2003; 14:e9.
31. Sheehan JP, Niranjan A, Sheehan JM, Jane JA Jr, Laws ER, Kondziolka D, Flickinger J, Landolt AM, Loeffler JS, Lunsford LD: Ste-reotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 2005; 102:678-691.
32. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M: Fractionated stereotactic confor-mal radiotherapy for secreting and nonse-creting pituitary adenomas. Clin Endocrinol (Oxf) 2006; 64:542-548.
33. Pollock BE, Cochran J, Natt N, Brown PD, Erickson D, Link MJ, Garces YI, Foote RL, Stafford SL, Schomberg PJ: Gamma knife ra-diosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys 2008; 70:1325-1329.
34. Losa M, Valle M, Mortini P, Franzin A, da Passano CF, Cenzato M, Bianchi S, Picozzi P, Giovanelli M: Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg 2004; 100: 438-444.
35. Jagannathan J, Yen CP, Pouratian N, Laws ER, Sheehan JP: Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and longterm results using the gamma knife. J Neu-rooncol 2009; 92:345-356.
36. Ganz JC: Gamma knife radiosurgery and its possible relationship to malignancy: a review. J Neurosurg 2002; 97:644-652.
37. Minniti G, Jaffrain-Rea ML, Osti M, Cantore G, Enrici RM: Radiotherapy for nonfunc-tioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. Neurosurg Rev 2007; 30: 167-175; dis-cussion 175-166.
38. Bradley KM, Adams CB, Potter CP, Wheeler DW, Anslow PJ, Burke CW: An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clin Endocri-nol (Oxf) 1994; 41:655-659.
39. Dekkers OM, Pereira AM, Roelfsema F, Voormolen JH, Neelis KJ, Schroijen MA, Smit JW, Romijn JA: Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2006; 91:1796-1801.
40. Ferrante E, Ferraroni M, Castrignano T, Me-nicatti L, Anagni M, Reimondo G, Del Monte P, Bernasconi D, Loli P, Faustini-Fustini M, Borretta G, Terzolo M, Losa M, Morabito A, Spada A, Beck-Peccoz P, Lania AG: Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocri-nol 2006; 155:823-829.
41. O'Sullivan EP, Woods C, Glynn N, Behan LA, Crowley R, O'Kelly P, Smith D, Thompson CJ, Agha A: The natural history of surgically treated but radiotherapy-naive non-functioning pituitary adenomas. Clin Endo-crinol (Ox f) 2009; 71: 709-714.
42. Turner HE, Stratton IM, Byrne JV, Adams CB, Wass JA: Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation-a follow-up study. Clin Endocrinol (Oxf) 1999; 51: 281-284.
43. van Lindert EJ, Grotenhuis JA, Meijer E: Results of follow-up after removal of non-functioning pituitary adenomas by transcranial surgery. Br J Neurosurg 1991; 5:129-133.
44. Brochier S, Galland F, Kujas M, Parker F, Gaillard S, Raftopoulos C, Young J, Alexopoulou O, Maiter D, Chanson P: Fac tors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur J Endocrinol 2010; 163: 193-200.
45. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. Ann Intern Med 2009; 151: 264-269, W264.
46. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012.
47. Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM: A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endo-crinol Metab 2008; 93: 666-673.
48. Fernandez-Balsells MM, Murad MH, Bar-wise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Perez L, Ponce de Leon-Lovaton PG, Erwin PJ, Carey J, Montori VM: Natural history of nonfunctioning pituitary adenomas and in-cidentalomas: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 905-912.
49. DerSimonian RLN: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
50. Ciric I, Mikhael M, Stafford T, Lawson L, Garces R: Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up resu lts. J Neurosurg 1983; 59: 395-401.
51. Halberg FS G: Radiotherapy ofpituitary tumours. Endocrinol Metab Clin 1987; 7:667-668.
52. Chun M MG, Hetelekidis S: Radiotherapy in the treatment of pituitary adenomas. Int J Radiat Oncol Biol Phys 1988; 15: 305-309.
53. Vlahovitch B, Reynaud C, Rhiati J, Mansour H, Hammoud F: Treatment and recurrences in 135 pituitary adenomas. Acta Neurochir Suppl (Wien) 1988; 42:120-123.
54. Shone GR, Richards SH, Hourihan MD, Hall R, Thomas JP, Scanlon MF: Non-secretory adenomas of the pituitary treated by trans-ethmoidal sellotomy. J R Soc Med 1991; 84: 140-143.
55. Sassolas G TJ, Treluyer C, Perrin G: Management of nonfunctioning pituitary adenomas. Acta Endocrinol (Copenh) 1993; 129(suppl 1): 21-26.
56. Lillehei KO, Kirschman DL, Kleinschmidt-De Masters BK, Ridgway EC: Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary mac-roadenomas. Neurosurgery 1998; 43:432-438.
57. van den Bergh AC, van den Berg G, Schoorl MA, Sluiter WJ, van der Vliet AM, Hoving EW, Szabo BG, Langendijk JA, Wolffenbuttel BH, Dullaart RP: Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys 2007; 67:863-869.
58. Soto-Ares G, Cortet-Rudelli C, Assaker R, Boulinguez A, Dubest C, Dewailly D, Pruvo JP: MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas. Eur J Endocrinol 2002; 146: 179-186.
59. Losa M, Mortini P, Barzaghi R, Ribotto P, Terreni MR, Marzoli SB, Pieralli S, Giovanel-li M: Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neuro-surg 2008; 108: 525-532.
60. Picozzi P, Losa M, Mortini P, Valle MA, Franzin A, Attuati L, Ferrari da Passano C, Giovanelli M: Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neu-rosurg 2005; 102(suppl):71-74.
61. Tanaka Y, Hongo K, Tada T, Sakai K, Kaki-zawa Y, Kobayashi S: Growth pattern and rate in residual nonfunctioning pituitary adenomas: Correlations among tumor volume doubling time, patient age, and mib-1 index. J Neurosurg 2003; 98:359-365.
62. Ekramullah SM, Saitoh Y, Arita N, Ohnishi T, Hayakawa T: The correlation of ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochir (Wien) 1996; 138: 1449-1455.
63. Coulter IC, Mukerji N, Bradey N, Connolly V, Kane PJ: Radiologic follow-up of non-functioning pituitary adenomas: rationale and cost effectiveness. J Neurooncol 2009; 93: 157-163.
64. Zhang X, Fei Z, Zhang J, Fu L, Zhang Z, Liu W, Chen Y: Management of nonfunctioning pituitary adenomas with suprasellar extensions by transsphenoidal microsurgery. Surg Neurol 1999; 52:380-385.
65. Hsu CY, Guo WY, Chien CP, Ho DM: Mib-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma. Eur J Endocrinol 2010; 162:1027-1033.
66. Honegger J, Zimmermann S, Psaras T, Petrick M, Mittelbronn M, Ernemann U, Reincke M, Dietz K: Growth modelling of non-functioning pituitary adenomas in patients referred for surgery. Eur J Endocrinol 2008; 158:287-294.
67. Greenman Y, Stern N: How should a non-functioning pituitary macroadenoma be monitored after debulking surgery? Clin En-docrinol (Oxf) 2009; 70: 829-832.
68. Dekkers OM, Pereira AM, Romijn JA: Treatment and follow-up of clinically nonfunc-tioning pituitary macroadenomas. J Clin En-docrinol Metab 2008; 93: 3717-3726.
69. Greenman Y, Stern N: Non-functioning pituitary adenomas. Best Pract Res Clin Endo-crinol Metab 2009; 23: 625-638.
70. Molitch ME: Nonfunctioning pituitary tumors and pituitary incidentalomas. Endo-crinol Metab Clin North Am 2008; 37: 151-171.